Association between Circulating Levels of 25-Hydroxyvitamin D 3 and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes. Scientific Publication

Background: Matrix metalloproteinase-10 (MMP-10) levels increase progressively starting from early diabetic kidney disease (DKD) stages. Vitamin D₃ (vitD₃) deficit is associated with a higher risk of diabetic microangiopathy. Reduced MMP-10 expression has been observed after exposure to vitD₃.

Aim: to assess how vitD₃ status is related to MMP-10 levels in patients with Type 2 diabetes (T2D).

Methods: 256 patients with T2D were included in this cross-sectional study. Demographic, clinical and serum MMP-10 and 25-hydroxyvitamin D₃ (25(OH)D₃) levels were collected from each patient. The association between MMP-10 and (25(OH)D₃) levels was assessed using a correlation analysis and fitting a multivariate linear regression model.

Results: Serum MMP-10 levels were inversely correlated with circulating 25(OH)D₃ (rho = -0.25; p< 0.001). In the subgroup analysis this correlation was significant in patients with DKD (rho = -0.28; p = 0.001) and in subjects with vitD₃ deficit (rho = -0.24; p = 0.005). In the regression model adjusted for kidney function, body adiposity, smoking and vitD supplementation MMP-10 levels were 68.7 pg/mL lower in patients with 25(OH)D₃ > 20 ng/mL, with respect to ≤20 ng/mL (p = 0.006).

Conclusions: vitD₃ repletion status is an independent predictor of MMP-10 levels in T2D patients. Perhaps, high 25(OH)D₃ values should be targeted in these patients in order to prevent vascular complications.

CITATION Nutrients. 2022 Aug 24;14(17):3484. doi: 10.3390/nu14173484